August 1997 - The CenterWatch Monthly : Volume 4, Issue 4, August 1997
A Failure to Reform
Despite all the attention on accelerating drug development, clinical development times are still lengthening.
Industry is remarkably slow to reform inefficient ways.
Successful reform would reduce industry spending on investigator grants for individual drugs, but would likely lead to an increase in number of drugs in pipeline.
Oncology CRO, PPM Team Up
Ilex Oncology issues $5.6 million in stock to Physician Reliance Network to gain preferred access to PPM's patients.
Ilex expects alliance to boost its CRO business.
- CRO News
- Site News
- Grant Leads